STOCK TITAN

Cemex S.A.B. de C.V. (CX) Financials

CX
FY2025 annual
Revenue $16.1B -0.4% YoY
Net Income $970.0M +1.0% YoY
EPS (Diluted) $0.01 YoY not available
Free Cash Flow $1.0B +15.0% YoY
Market Cap $13.8B as of Oct 3, 2026
Price / Sales 0.9x on $16.1B revenue, FY2025
Price / Earnings 14.2x on $970.0M net income, FY2025
Price / Book 1.1x on $12.5B equity, Q3 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Apr 24, 2026 Reported Currency USD FYE April

Newest figures come from the 10-K for FY2025, filed Apr 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CX SEC filings page.

Cemex S.A.B. de C.V. (CX) reported $16.1B in revenue for fiscal year 2025, down 0.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CX FY2025

CEMEX generates cash well above reported profit and has sharply reduced long-term debt, while short-term obligations remain heavier than current assets.

In FY2025, operating cash flow reached $1.98B against net income of $970M, so reported earnings understated the cash produced by operations. Free cash flow was $1.03B after $947M of capital spending, indicating reinvestment consumed about half of operating cash rather than absorbing it all.

Long-term debt fell to $1.38B in FY2025 from $5.53B in FY2024, a major shift in financing structure. Debt-to-equity reached 0.1x, but the current ratio remained 0.8x, meaning deleveraging has not translated into a surplus of current assets over current liabilities.

Revenue stayed near $16B in FY2024 and FY2025 while net margin held around 6.0%, so the latest earnings improvement was not driven by a larger top line. The combination points to margin or below-revenue-line factors, although these fields do not identify whether mix, costs, or taxes did the work.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 28 / 100
Financial Health Score 28/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cemex S.A.B. de C.V.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Cemex S.A.B. de C.V., and counted as zero in the overall score.

Growth
26

Cemex S.A.B. de C.V.'s revenue declined 0.4% year-over-year, from $16.2B to $16.1B. This contraction results in a growth score of 26/100.

Leverage
80

Cemex S.A.B. de C.V. carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 80/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
12

Cemex S.A.B. de C.V.'s current ratio of 0.83 is below the typical benchmark, resulting in a score of 12/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
52

Cemex S.A.B. de C.V. has a free cash flow margin of 6.4%, earning a moderate score of 52/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
0

Not available for Cemex S.A.B. de C.V., and counted as zero in the overall score.

Piotroski F-Score Partial
6/8

Cemex S.A.B. de C.V. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
2.04x

For every $1 of reported earnings, Cemex S.A.B. de C.V. generates $2.04 in operating cash flow ($2.0B OCF vs $970.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q3 2025.

Cash & Balance Sheet

Cash & Debt
$864.0M
YoY+38.5%
QoQ+38.5%

Cemex S.A.B. de C.V. held $864.0M in cash against $5.5B in long-term debt as of Q3 2025.

Shares Outstanding
14.51B
YoY+0.1%
QoQ+0.1%

Cemex S.A.B. de C.V. had 14.51B shares outstanding in Q3 2025. This represents an increase of 0.1% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Free Cash Flow

Not reported for Q3 2025.

Dividends Per Share

Not reported for Q3 2025.

Margins & Returns

None of these metrics is reported for Q3 2025.

Capital Allocation

None of these metrics is reported for Q3 2025.

CX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CX quarterly income statement
MetricQ3'2510-KQ3'2410-KQ3'2310-KQ3'2210-KQ3'2110-KQ3'2010-KQ3'1910-KQ3'1810-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CX quarterly balance sheet
MetricQ3'2510-KQ3'2410-KQ3'2310-KQ3'2210-KQ3'2110-KQ3'2010-KQ3'1910-KQ3'1810-K
Total Assets$27.3B-4.0%$28.4B+7.5%$26.4B-0.8%$26.6B-2.8%$27.4B-6.6%$29.4B+0.6%$29.2B-2.4%$29.9B+0.2%
Current Assets$5.0B+0.2%$5.0B+10.6%$4.5B+7.1%$4.2B-0.2%$4.2B-7.5%$4.6B+33.8%$3.4B-5.9%$3.6B-14.9%
Cash & Equivalents$864.0M+38.5%$624.0M+26.1%$495.0M-19.2%$613.0M-35.5%$950.0M+20.6%$788.0M+155.0%$309.0M-55.8%$699.0M+24.6%
Inventory$1.5B-17.0%$1.8B+7.2%$1.7B+32.4%$1.3B+29.9%$971.0M-1.8%$989.0M-8.5%$1.1B+12.7%$959.0M
Goodwill$7.4B-3.0%$7.7B+1.8%$7.5B-5.6%$8.0B-6.1%$8.5B-11.0%$9.6B-3.5%$9.9B-0.4%$9.9B-0.1%
Total Liabilities$14.8B-9.2%$16.3B+5.0%$15.5B-5.1%$16.4B-11.3%$18.5B-0.4%$18.5B+2.3%$18.1B-6.0%$19.3B-5.6%
Current Liabilities$6.1B-10.2%$6.8B+22.4%$5.5B+3.1%$5.4B+0.5%$5.4B-1.1%$5.4B+12.8%$4.8B-18.8%$5.9B+37.5%
Non-Current Liabilities$8.7B-8.4%$9.5B-4.6%$10.0B-9.2%$11.0B-16.2%$13.1B-0.1%$13.1B-1.5%$13.3B-0.4%$13.4B-17.1%
Long-Term Debt$5.5B-11.2%$6.2B-10.7%$7.0B-5.5%$7.4B-21.0%$9.3B-0.3%$9.4B+0.6%$9.3B-5.7%$9.9B-13.4%
Total Equity$12.5B+3.0%$12.1B+11.1%$10.9B+6.2%$10.3B+14.7%$9.0B-17.3%$10.8B-2.1%$11.1B+4.3%$10.6B+11.6%
Retained Earnings$5.2B+18.5%$4.4B+4.3%$4.2B+25.3%$3.4B+28.6%$2.6B+62.6%$1.6B-0.1%$1.6B+45.5%$1.1B+34.5%

Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.

CX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CX quarterly cash flow statement
MetricQ3'2510-KQ3'2410-KQ3'2310-KQ3'2210-KQ3'2110-KQ3'2010-KQ3'1910-KQ3'1810-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

CX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CX quarterly financial ratios
MetricQ3'2510-KQ3'2410-KQ3'2310-KQ3'2210-KQ3'2110-KQ3'2010-KQ3'1910-KQ3'1810-K
Current Ratio0.82+0.1x0.74-0.1x0.820.0x0.790.0x0.79-0.1x0.85+0.1x0.71+0.1x0.62-0.4x
Debt-to-Equity0.44-0.1x0.51-0.1x0.64-0.1x0.72-0.3x1.04+0.2x0.870.0x0.84-0.1x0.93-0.3x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Cemex S.A.B. de C.V. CX FY2025 $16.1B $970.0M 6.0% $13.8B 28/100
James Hardie Industries plc JHX FY2026 $4.8B $104.0M 2.1% $14.5B 54/100
Vulcan Materials Company(Holding Company) VMC FY2025 $7.9B $1.1B 13.6% $31.5B 62/100
Martin Marietta Materials MLM FY2025 $6.2B $1.1B 18.5% $34.3B 64/100
CRH Public Limited Company CRH FY2025 $37.4B $3.8B 10.0% $54.5B 58/100
Eagle Materials, Inc. EXP FY2026 $2.3B $423.8M 18.4% $5.3B 72/100

Frequently Asked Questions

What is Cemex S.A.B. de C.V.'s annual revenue?

Cemex S.A.B. de C.V. (CX) reported $16.1B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cemex S.A.B. de C.V.'s revenue growing?

Cemex S.A.B. de C.V. (CX) revenue declined by 0.4% year-over-year, from $16.2B to $16.1B in fiscal year 2025.

Is Cemex S.A.B. de C.V. profitable?

Yes, Cemex S.A.B. de C.V. (CX) reported a net income of $970.0M in fiscal year 2025, with a net profit margin of 6.0%.

Cemex S.A.B. de C.V. (CX) reported diluted earnings per share of $0.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Cemex S.A.B. de C.V. (CX) had $1.8B in cash and equivalents against $1.4B in long-term debt.

Cemex S.A.B. de C.V. (CX) had a net profit margin of 6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Cemex S.A.B. de C.V. (CX) has a return on equity of 7.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cemex S.A.B. de C.V. (CX) generated $1.0B in free cash flow during fiscal year 2025. This represents a 15.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cemex S.A.B. de C.V. (CX) generated $2.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cemex S.A.B. de C.V. (CX) had $28.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Cemex S.A.B. de C.V. (CX) invested $947.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Cemex S.A.B. de C.V. (CX) had 14.51B shares outstanding as of fiscal year 2025.

Cemex S.A.B. de C.V. (CX) had a current ratio of 0.83 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Cemex S.A.B. de C.V. (CX) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cemex S.A.B. de C.V. (CX) had a return on assets of 3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cemex S.A.B. de C.V. (CX) trades at 14.2x earnings, its market capitalization divided by net income of $970.0M net income, FY2025. The market capitalization is $13.8B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cemex S.A.B. de C.V. (CX) trades at 0.9x sales, its market capitalization divided by revenue of $16.1B revenue, FY2025. The market capitalization is $13.8B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cemex S.A.B. de C.V. (CX) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cemex S.A.B. de C.V. (CX) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cemex S.A.B. de C.V. (CX) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top